Companies included in RSPH
This is RSPH's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–62 of 62.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| Invesco Private Prime Fund | Invesco Private Prime Fund | 23,165,051 | NS | 3.360318% |
| CNC | Centene Corp. | 341,770 | NS | 2.661528% |
| HUM | Humana Inc. | 71,670 | NS | 2.457888% |
| UNH | UnitedHealth Group Inc. | 42,960 | NS | 2.308515% |
| ELV | Elevance Health, Inc. | 42,274 | NS | 2.308074% |
| WST | West Pharmaceutical Services, Inc. | 51,423 | NS | 2.219624% |
| CI | Cigna Group (The) | 46,964 | NS | 1.979404% |
| CVS | CVS Health Corp. | 161,859 | NS | 1.95539% |
| VTRS | Viatris Inc. | 877,255 | NS | 1.900992% |
| MTD | Mettler-Toledo International Inc. | 9,989 | NS | 1.849626% |
| WAT | Waters Corp. | 41,194 | NS | 1.847648% |
| TECH | Bio-Techne Corp. | 228,582 | NS | 1.834121% |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | 204,319 | NS | 1.795616% |
| ALGN | Align Technology, Inc. | 70,100 | NS | 1.789613% |
| INCY | Incyte Corp. | 129,466 | NS | 1.789022% |
| DVA | DaVita Inc. | 79,156 | NS | 1.781195% |
| A | Agilent Technologies, Inc. | 106,168 | NS | 1.779374% |
| SOLV | Solventum Corp. | 181,227 | NS | 1.770634% |
| BIIB | Biogen Inc. | 64,351 | NS | 1.766704% |
| CRL | Charles River Laboratories International, Inc. | 72,551 | NS | 1.757056% |
| EW | Edwards Lifesciences Corp. | 144,044 | NS | 1.744558% |
| STE | Steris PLC | 55,331 | NS | 1.740571% |
| PFE | Pfizer Inc. | 448,934 | NS | 1.738591% |
| HSIC | Henry Schein, Inc. | 160,221 | NS | 1.73342% |
| BAX | Baxter International Inc. | 678,988 | NS | 1.731349% |
| DGX | Quest Diagnostics Inc. | 61,100 | NS | 1.721053% |
| RVTY | Revvity, Inc. | 136,740 | NS | 1.717978% |
| TMO | Thermo Fisher Scientific Inc. | 24,717 | NS | 1.717112% |
| ZTS | Zoetis Inc. | 102,307 | NS | 1.706057% |
| LH | Labcorp Holdings Inc. | 45,318 | NS | 1.687988% |
| JNJ | Johnson & Johnson | 50,444 | NS | 1.681736% |
| MRK | Merck & Co., Inc. | 105,475 | NS | 1.670307% |
| Eli Lilly and Co. | Eli Lilly and Co. | 12,275 | NS | 1.663991% |
| IDXX | IDEXX Laboratories, Inc. | 20,408 | NS | 1.660016% |
| ISRG | Intuitive Surgical, Inc. | 24,863 | NS | 1.650261% |
| ABBV | AbbVie Inc. | 53,813 | NS | 1.649421% |
| IQV | IQVIA Holdings Inc. | 71,445 | NS | 1.641151% |
| AMGN | Amgen Inc. | 32,465 | NS | 1.630455% |
| DHR | Danaher Corp. | 62,812 | NS | 1.63034% |
| Becton, Dickinson and Co. | Becton, Dickinson and Co. | 75,110 | NS | 1.623695% |
| REGN | Regeneron Pharmaceuticals, Inc. | 15,819 | NS | 1.622329% |
| SYK | Stryker Corp. | 35,426 | NS | 1.619256% |
| MDT | Medtronic PLC | 137,730 | NS | 1.617545% |
| UHS | Universal Health Services, Inc. | 65,802 | NS | 1.606015% |
| DXCM | DexCom, Inc. | 184,832 | NS | 1.596477% |
| GILD | Gilead Sciences, Inc. | 83,938 | NS | 1.592953% |
| CAH | Cardinal Health, Inc. | 56,891 | NS | 1.591602% |
| ResMed Inc. | ResMed Inc. | 51,051 | NS | 1.583201% |
| COR | Cencora, Inc. | 35,003 | NS | 1.563773% |
| ZBH | Zimmer Biomet Holdings, Inc. | 130,775 | NS | 1.563557% |
| MCK | McKesson Corp. | 13,108 | NS | 1.549902% |
| VRTX | Vertex Pharmaceuticals Inc. | 24,889 | NS | 1.542856% |
| Cooper Cos., Inc. (The) | Cooper Cos., Inc. (The) | 166,179 | NS | 1.516109% |
| GEHC | GE HealthCare Technologies Inc. | 168,699 | NS | 1.488694% |
| BSX | Boston Scientific Corp. | 176,025 | NS | 1.470876% |
| ABT | Abbott Laboratories | 111,156 | NS | 1.463776% |
| MRNA | Moderna, Inc. | 218,977 | NS | 1.459127% |
| HCA | HCA Healthcare, Inc. | 22,813 | NS | 1.43756% |
| PODD | Insulet Corp. | 51,298 | NS | 1.280814% |
| Invesco Private Government Fund | Invesco Private Government Fund | 8,568,806.22 | NS | 1.242865% |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio | 237,797.14 | NS | 0.034491% |
| TPG Inc. | TPG Inc. | 162,788 | NS | 0% |
SEC N-PORT snapshot as of .